Bismuth Subcitrate Potassium, Metronidazole and Tetracycline Hydrochloride
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
61269-386 -
Package NDC
61269-386-12 -
Application number
NDA050786 -
SPL ID
fa1bf0cb-c69b-40d1-b543-828ca1cd5b58 -
SPL set ID
c29bfde9-5eb4-422a-bd30-4bce45e73dc0 -
UNII
R3O80H60KX -
UNII
140QMO216E -
UNII
P6R62377KV
What the source publishes
- Labeler
- H2-Pharma, LLC
- Active ingredients
- Bismuth Subcitrate Potassium, Metronidazole and Tetracycline Hydrochloride
- Form
- CAPSULE
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- NDA AUTHORIZED GENERIC
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
- Bismuth Subcitrate Potassium, Metronidazole and Tetracycline Hydrochloride
- BISMUTH SUBCITRATE POTASSIUM
- METRONIDAZOLE
- TETRACYCLINE HYDROCHLORIDE
Complete source data
{
"name": "Bismuth Subcitrate Potassium, Metronidazole and Tetracycline Hydrochloride",
"splId": "fa1bf0cb-c69b-40d1-b543-828ca1cd5b58",
"labels": [
{
"setId": "c29bfde9-5eb4-422a-bd30-4bce45e73dc0",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c29bfde9-5eb4-422a-bd30-4bce45e73dc0",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c29bfde9-5eb4-422a-bd30-4bce45e73dc0"
}
],
"routes": [
"ORAL"
],
"labeler": "H2-Pharma, LLC",
"finished": true,
"packaging": [
{
"sample": false,
"description": "10 BLISTER PACK in 1 BOX (61269-386-12) / 12 CAPSULE in 1 BLISTER PACK",
"package_ndc": "61269-386-12",
"identifierStatus": "well-formed",
"marketing_end_date": "20261120",
"marketing_start_date": "20250701"
}
],
"productId": "61269-386_fa1bf0cb-c69b-40d1-b543-828ca1cd5b58",
"useDomain": "unknown",
"dosageForm": "CAPSULE",
"productNdc": "61269-386",
"deaSchedule": null,
"genericName": "Bismuth Subcitrate Potassium, Metronidazole and Tetracycline Hydrochloride",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": "20261120",
"activeIngredients": [
{
"name": "BISMUTH SUBCITRATE POTASSIUM",
"strength": "140 mg/1"
},
{
"name": "METRONIDAZOLE",
"strength": "125 mg/1"
},
{
"name": "TETRACYCLINE HYDROCHLORIDE",
"strength": "125 mg/1"
}
],
"applicationNumber": "NDA050786",
"marketingCategory": "NDA AUTHORIZED GENERIC",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20250701",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000175435",
"M0014907"
],
"unii": [
"R3O80H60KX",
"140QMO216E",
"P6R62377KV"
],
"spl_set_id": [
"c29bfde9-5eb4-422a-bd30-4bce45e73dc0"
],
"pharm_class_cs": [
"Nitroimidazoles [CS]"
],
"pharm_class_epc": [
"Nitroimidazole Antimicrobial [EPC]"
],
"manufacturer_name": [
"H2-Pharma, LLC"
],
"is_original_packager": [
true
]
},
"listingExpirationDate": null
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:61269-386_fa1bf0cb-c69b-40d1-b543-828ca1cd5b58"